bpc 157 sinus infection BPC-157 Nasal Spray Open MedScience
Description
Conversely, among the samples without the declared API, 20.6% contained neither a declared API nor any API, while 14.3% had other undeclared APIs
Peptide therapy offers intriguing possibilities but remains in the early stages of research
Who is a good candidate for BPC-157 and TB-500 peptide therapy
The best hope for BPC is that this new regulatory environment allows for oral versions of the peptide to continue as OTC supplements (no GRAS indication has been given) while injectable forms are prescribed with modifications through compounding pharmacies as PDA or N-acetyl-BPC-157
